Literature DB >> 2390292

Free carnitine and acylcarnitine levels in sera of alcoholics.

C Alonso de la Peña1, I Rozas, A Alvarez-Prechous, M C Pardiñas, J M Paz, S Rodriguez-Segade.   

Abstract

We report the free, acyl-, and total carnitine contents of 49 clinically healthy volunteers and 167 chronic alcoholics with various clinically and/or anatomopathologically identified degrees of hepatic affection. There was a gradual upward trend in carnitine levels as the degree of hepatic affection increased. In cirrhotic patients, both free and acylcarnitine levels were significantly higher than normal, but there was no systematic hypercarnitinemia in other stages of alcoholism; on the contrary, noncirrhotic alcoholic patients accounted for 82.6% of all hypocarnitinemia cases. Hypercarnitinemia among cirrhotic alcoholics was due chiefly to increased free carnitine concentrations. Acylcarnitine levels in patients with hepatic steatosis were significantly higher than those in normal subjects (P less than 0.001), but there were no other statistically significant differences in either acyl- or free carnitine levels between normals on the one hand and, on the other, patients with hepatic steatosis, alcoholic hepatitis, slight hepatopathy, or chronic hepatopathy without portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390292     DOI: 10.1016/0885-4505(90)90047-5

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  4 in total

Review 1.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

2.  Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.

Authors:  Asem I Fitian; David R Nelson; Chen Liu; Yiling Xu; Miguel Ararat; Roniel Cabrera
Journal:  Liver Int       Date:  2014-04-28       Impact factor: 5.828

Review 3.  Carnitine in Alcohol Use Disorders: A Scoping Review.

Authors:  A Brianne Bota; John Graydon Simmons; Alicia DiBattista; Kumanan Wilson
Journal:  Alcohol Clin Exp Res       Date:  2021-03-07       Impact factor: 3.455

Review 4.  Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Mostafa Rezaei-Tavirani; Mohammad Mahboubi; Maryam Peyvandi; Farshad Okhovatian; Mona Zamanian-Azodi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.